In response to a number of enquiries about companies selling miraculous stem-cell containing therapeutic products who are offering participation in an “IRB-cleared” clinical study, I would urge physicians to be cautious before signing up. In my opinion, there are a number of issues here, including smoke screens by companies that want to make a buck,...Read More